Skip to main navigation Skip to search Skip to main content

Catholic University of Korea Researcher Has Provided New Data on Glioblastomas (Ctni-26. Efficacy And Safety of Metformin Plus Low-dose Temozolomide in Patients With Recurrent Or Refractory Glioblastoma: A Randomized, Prospective, Multicenter, ...)

Press/Media

Period24 Nov 2023

Media coverage

1

Media coverage

  • TitleCatholic University of Korea Researcher Has Provided New Data on Glioblastomas (Ctni-26. Efficacy And Safety of Metformin Plus Low-dose Temozolomide in Patients With Recurrent Or Refractory Glioblastoma: A Randomized, Prospective, Multicenter, ...)
    Media name/outletClinical Oncology Daily
    Country/TerritoryUnited States
    Date24/11/23
    PersonsTae Min Kim, Youn Soo Lee